Health Times Lithuania
SEE OTHER BRANDS

The best health and wellness news from Lithuania

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health Times Lithuania.

Matsato Chef Knife: Why Matsato Knife Precision-Crafted Japanese Blade Is Gaining Global Recognition in 2025

Matsato Chef Knife: Why Matsato Knife Precision-Crafted Japanese Blade Is Gaining Global Recognition in 2025

New York City, NY, July 02, 2025 (GLOBE NEWSWIRE) -- The Matsato Chef Knife has quickly risen to prominence among professional chefs and home cooks, thanks to an uncompromising commitment to detail. Each blade is forged using centuries-old...

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and introducing revenue guidance of $12-$16 million...

Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk

Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk

Norwalk, CT / USA, June 16, 2025 (GLOBE NEWSWIRE) -- Norwalk, CT — Advanced Dental Center in Norwalk, Connecticut, led by Dr. Elad Yossefi and Dr. Tal Yossefi, is introducing new technology-driven services to improve patient care. Located on Main...

Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update

Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update

Enrollment and dosing underway in Phase 3 clinical trial (the “MIRACLE” trial) evaluating Annamycin (naxtarubicin) for the treatment of R/R AML Regulatory and site selection progress to date supports interim data readout expected in the second...

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Encouraging results of Cohort A data from the ASCEND trial presented at ASCO-GI 2025; Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025 Cash runway extending into the third quarter of 2026 with no debt...

Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee

Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee

-- PCRX-201 demonstrated two years of clinically meaningful improvements in pain, stiffness and function across all structural severity subgroups, including advanced disease -- -- Study Findings Presented at 2025 OARSI World Congress-- BRISBANE,...

Economic Bulletin Issue 4, 2025

Economic Bulletin Issue 4, 2025

Overview At its meeting on 5 June 2025, the Governing Council decided to lower the three key ECB interest rates by 25 basis points. In particular, the decision to lower the deposit facility rate – the rate through which the Governing Council...

Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101

Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101

Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment of platinum resistant ovarian cancer (PROC) with expansion opportunities into endometrial,...

Bioma Review 2025: Weight Loss Probiotic or Just Another Scam? - Ingredients & Side Effects Revealed !! By Bioma

Bioma Review 2025: Weight Loss Probiotic or Just Another Scam? - Ingredients & Side Effects Revealed !! By Bioma

Birštonas Lithuania, April 20, 2025 (GLOBE NEWSWIRE) -- Are you looking for a reliable solution to improve your gut health and overall well-being? Bioma Probiotic could be the answer you've been searching for. This article delves into everything...

Mushroom Market Size to Projected at 32.04 Million Tonnes by 2032, Growing at 7.18% CAGR (2024–2032)

Mushroom Market Size to Projected at 32.04 Million Tonnes by 2032, Growing at 7.18% CAGR (2024–2032)

Key companies covered in the mushroom market report are BioFungi GmbH, Nasza Chata, Ecolink Baltic, Monterey Mushrooms, Ecolink Baltic, and Others. NY, UNITED STATES, May 22, 2025 /⁨EINPresswire.com⁩/ -- The global mushroom market reached 17.25...

Clairu Reviews: Don’t Buy This Air Purifier Till You’ve Read This Unbiased Report!

Clairu Reviews: Don’t Buy This Air Purifier Till You’ve Read This Unbiased Report!

KAUNAS, Lithuania, May 16, 2025 (GLOBE NEWSWIRE) -- Due to yearnings of our readers for in-depth and honest Clairu Air Purifier Reviews in the United States, Australia, UK and Canada, we completely went out of our way to research and analyze this...

EMBank Showcases Visionary Leadership at Baltic Fintech Days 2025

EMBank Showcases Visionary Leadership at Baltic Fintech Days 2025

Baltic Fintech Days, spotlighting innovation, disruption, and collaboration across the financial technology landscape. VILNIUS, LITHUANIA, April 10, 2025 /⁨EINPresswire.com⁩/ -- Last week, Vilnius welcomed the fintech world to the vibrant two-day...

Immutep Quarterly Activities Report Q3 FY25

Immutep Quarterly Activities Report Q3 FY25

Media Release First patient safely dosed in TACTI-004 Phase III lung cancer trial, marking a significant milestone Pivotal TACTI-004 trial design presented at the European Lung Cancer Congress (ELCC) 2025 Patient enrolment completed for the...

Trump administration sends migrants to Guantanamo Bay

Trump administration sends migrants to Guantanamo Bay

(MENAFN) The Trump administration is preparing to relocate as many as 9,000 undocumented migrants to the US detention center at Guantanamo Bay, Cuba, as early as this week, according to reports. Officials revealed that the group of migrants...

Trump Administration Prepares to Relocate Thousands of Migrants to Guantanamo Bay

Trump Administration Prepares to Relocate Thousands of Migrants to Guantanamo Bay

(MENAFN) The Trump administration is preparing to relocate as many as 9,000 undocumented migrants to the US detention center at Guantanamo Bay, Cuba, with transfers potentially beginning this week, media outlets revealed Tuesday. Officials...

Trump Administration Plans Migrant Transfers

Trump Administration Plans Migrant Transfers

(MENAFN) The Trump administration is preparing to transfer as many as 9,000 undocumented immigrants to the U.S. detention center located in Guantanamo Bay, Cuba, possibly beginning this week, according to reports from media outlets. Government...

Correction: Half a year of AB Akola Group: net profit grew by more than a third

Correction: Half a year of AB Akola Group: net profit grew by more than a third

AB Akola Group taking into account the result of the unscheduled inspection of the Company implemented by the Financial Market Supervision Department of the Bank of Lithuania and the terms specified in the administrative agreement concluded on 8...

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

-- Poster to be presented at OARSI World Congress on Osteoarthritis -- BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain...

First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer

First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer

First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for Immutep Global Phase III with efti will enrol approximately 756 patients at more than 150 clinical sites Trial results will inform...

Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technology

Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technology

VILNIUS, Lithuania, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Atrandi Biosciences, a life sciences company pioneering next-generation single-cell analysis technology, today announced a $25 million Series A funding round led by Lux Capital, with...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service